Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

David Taylor to become new P&G chief executive

Succeeds A.G. Lafley who will stay on as chairman

- PMLiVE

Merck hopes for another Keytruda with new immunotherapy deal

US firm signs pact with cCAM Biotherapeutics for cancer research

- PMLiVE

Is bigger always better in clinical outsourcing?

Opinions differ on whether size is an advantage when working with a CRO

AstraZeneca AZ

Setback for AZ’s MEK inhibitor selumetinib

Drug fails at phase III in uveal melanoma

Sanofi reception

Sanofi and Regeneron extend partnership to cancer

Sanofi will pay more than $2bn to the firm for immunotherapy research

healthcare data technology

Quarter of UK patients now diagnosing online

Survey finds people would rather self-diagnose symptoms than wait for GP appointment

- PMLiVE

Teva buys Allergan generics unit for $40.5bn

Will now drop its six-month pursuit of Mylan

- PMLiVE

EATRIS and the new age of partnering

Anton Ussi on the institute's long-term plans

EU flag

Shire and Baxalta drugs among CHMP’s latest recommendations

New drugs for ADHD and haemophilia backed forEuropean approval

RRD International hires Ulrich Thienel as CDMO

Company expands leadership team with former Takeda VP

- PMLiVE

Sanofi’s cholesterol drug Praluent backed for European approval

CHMPdecision puts firm on-course to catch up with Amgen's Repatha

Biogen’s Douglas Williams departs for biotech start-up

Research head will be first member of a new cancer-focused firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links